Edition:
United Kingdom

Adamis Pharmaceuticals Corp (ADMP.OQ)

ADMP.OQ on NASDAQ Stock Exchange Capital Market

0.75USD
9:00pm BST
Change (% chg)

$-0.01 (-1.96%)
Prev Close
$0.76
Open
$0.76
Day's High
$0.78
Day's Low
$0.73
Volume
91,560
Avg. Vol
100,940
52-wk High
$4.25
52-wk Low
$0.70

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.09 December 18 Sep 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 2 2 2
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.33 2.33 2.33 2.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 3 6.19 6.75 5.80 11.60
Quarter Ending Dec-19 3 5.88 7.10 5.25 12.04
Year Ending Dec-19 3 22.82 25.06 21.20 34.17
Year Ending Dec-20 2 35.27 43.83 26.70 48.61
Earnings (per share)
Quarter Ending Sep-19 3 -0.09 -0.07 -0.11 0.01
Quarter Ending Dec-19 3 -0.09 -0.07 -0.11 0.01
Year Ending Dec-19 3 -0.47 -0.41 -0.53 -0.39
Year Ending Dec-20 2 -0.26 -0.22 -0.30 -0.14

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-19 5.79 4.91 0.89 15.29
Quarter Ending Dec-18 5.47 4.15 1.31 24.00
Quarter Ending Sep-18 5.23 3.83 1.39 26.65
Quarter Ending Jun-18 3.98 3.92 0.06 1.57
Quarter Ending Mar-18 3.58 3.18 0.40 11.08

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 6.19 6.14 6.14 6.14 11.60
Quarter Ending Dec-19 5.88 6.39 6.39 6.39 12.04
Year Ending Dec-19 22.82 23.03 23.03 23.03 34.17
Year Ending Dec-20 35.27 35.27 35.27 35.27 48.61

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-19 1 0 1 0
Quarter Ending Dec-19 0 1 0 1
Year Ending Dec-19 0 1 0 1
Year Ending Dec-20 0 0 0 0
Earnings